Avanos Medical (AVNS) Cash from Operations (2016 - 2024)
Historic Cash from Operations for Avanos Medical (AVNS) over the last 12 years, with Q4 2024 value amounting to $57.9 million.
- Avanos Medical's Cash from Operations rose 35590.55% to $57.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $100.7 million, marking a year-over-year increase of 21080.25%. This contributed to the annual value of $100.7 million for FY2024, which is 21080.25% up from last year.
- Avanos Medical's Cash from Operations amounted to $57.9 million in Q4 2024, which was up 35590.55% from $23.0 million recorded in Q3 2024.
- Over the past 5 years, Avanos Medical's Cash from Operations peaked at $57.9 million during Q4 2024, and registered a low of -$8.0 million during Q1 2024.
- Its 5-year average for Cash from Operations is $15.4 million, with a median of $14.0 million in 2021.
- As far as peak fluctuations go, Avanos Medical's Cash from Operations soared by 463636.36% in 2021, and later tumbled by 47777.78% in 2023.
- Over the past 5 years, Avanos Medical's Cash from Operations (Quarter) stood at $1.1 million in 2020, then surged by 4636.36% to $52.1 million in 2021, then crashed by 35.32% to $33.7 million in 2022, then tumbled by 62.31% to $12.7 million in 2023, then soared by 355.91% to $57.9 million in 2024.
- Its Cash from Operations was $57.9 million in Q4 2024, compared to $23.0 million in Q3 2024 and $27.8 million in Q2 2024.